Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; elect...
Acutaas Chemicals reported revenue of 10.00 billion INR for fiscal year 2025, up 40.2% from fiscal year 2024, and net income of 1.59 billion INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 3.93 billion INR, up 43.0% from a year before. Its market capitalization was 257.41 billion INR as of October 12, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 12, 2026.
No profile data available.